Related Experiment Video

Updated: May 19, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Inhibition of cholesterol absorption: targeting the intestine

Stephen D Lee1, Pavel Gershkovich, Jerald W Darlington

  • 1Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, British Columbia, V6T 1Z3, Canada. Stephen.Lee@alumni.ubc.ca

Pharmaceutical Research
|August 28, 2012
PubMed

Insights

Targeting cholesterol absorption in the gut offers a novel approach to manage hypercholesterolemia and coronary artery disease (CAD). This strategy complements statins by addressing dietary cholesterol, a key factor in managing elevated cholesterol levels.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Gastroenterology

Background:

  • Atherosclerosis, driven by lipid-rich plaque, causes Coronary Artery Disease (CAD), a leading global mortality cause.
  • Hypercholesterolemia is a primary risk factor for CAD.
  • Statins, effective in reducing cholesterol biosynthesis, were approved in 1987 but do not address cholesterol absorption.

Purpose of the Study:

  • To explore therapeutic strategies targeting gastrointestinal cholesterol absorption.
  • To identify adjunct therapies for hypercholesterolemia not adequately managed by statins alone.
  • To focus on localized gastrointestinal targeting to minimize systemic side effects.

Main Methods:

  • Review of therapeutic approaches aimed at inhibiting cholesterol absorption in the gastrointestinal tract.
  • Emphasis on strategies specifically targeting the gastrointestinal system.
  • Analysis of methods to avoid off-target effects associated with systemic drug exposure.

Main Results:

  • Cholesterol absorption inhibition presents a viable target for combination therapies in hypercholesterolemia.
  • Gastrointestinal-specific targeting offers a promising route to enhance cholesterol-lowering efficacy.
  • Localized action in the gut may reduce systemic adverse events compared to broader interventions.

Conclusions:

  • Targeting gastrointestinal cholesterol absorption is a crucial strategy for managing hypercholesterolemia.
  • Combination therapies involving statins and absorption inhibitors are needed for effective CAD risk reduction.
  • Localized gastrointestinal therapies offer a safer alternative for managing elevated cholesterol levels.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Drug Absorption: Factors Affecting GI Absorption01:19

Drug Absorption: Factors Affecting GI Absorption

The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
In...